IL120082A0 - Method for determining the amount of an amylin receptor binding compound in a sample - Google Patents

Method for determining the amount of an amylin receptor binding compound in a sample

Info

Publication number
IL120082A0
IL120082A0 IL12008297A IL12008297A IL120082A0 IL 120082 A0 IL120082 A0 IL 120082A0 IL 12008297 A IL12008297 A IL 12008297A IL 12008297 A IL12008297 A IL 12008297A IL 120082 A0 IL120082 A0 IL 120082A0
Authority
IL
Israel
Prior art keywords
amylin
sample
determining
amount
receptor binding
Prior art date
Application number
IL12008297A
Other languages
English (en)
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of IL120082A0 publication Critical patent/IL120082A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
IL12008297A 1991-03-15 1997-01-27 Method for determining the amount of an amylin receptor binding compound in a sample IL120082A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/670,231 US5264372A (en) 1991-03-15 1991-03-15 Receptor-based screening methods for amylin agonists and antagonists
IL101233A IL101233A (en) 1991-03-15 1992-03-15 Receptor-based screening and identifying methods for amylin agonists and antagonists

Publications (1)

Publication Number Publication Date
IL120082A0 true IL120082A0 (en) 1997-04-15

Family

ID=24689539

Family Applications (5)

Application Number Title Priority Date Filing Date
IL12008292A IL120082A (en) 1991-03-15 1992-03-15 A method for determining the amount of a substance that binds to an amylin receptor in the sample
IL101233A IL101233A (en) 1991-03-15 1992-03-15 Receptor-based screening and identifying methods for amylin agonists and antagonists
IL12008192A IL120081A (en) 1991-03-15 1992-03-15 Methods for determining trait-related properties of amylin agonists and antagonists
IL12008197A IL120081A0 (en) 1991-03-15 1997-01-27 Assay for evaluating the receptor binding characteristics of amylin agonists and antagonists
IL12008297A IL120082A0 (en) 1991-03-15 1997-01-27 Method for determining the amount of an amylin receptor binding compound in a sample

Family Applications Before (4)

Application Number Title Priority Date Filing Date
IL12008292A IL120082A (en) 1991-03-15 1992-03-15 A method for determining the amount of a substance that binds to an amylin receptor in the sample
IL101233A IL101233A (en) 1991-03-15 1992-03-15 Receptor-based screening and identifying methods for amylin agonists and antagonists
IL12008192A IL120081A (en) 1991-03-15 1992-03-15 Methods for determining trait-related properties of amylin agonists and antagonists
IL12008197A IL120081A0 (en) 1991-03-15 1997-01-27 Assay for evaluating the receptor binding characteristics of amylin agonists and antagonists

Country Status (13)

Country Link
US (1) US5264372A (xx)
EP (1) EP0529065B1 (xx)
JP (1) JPH05508226A (xx)
AT (1) ATE172540T1 (xx)
AU (1) AU1663092A (xx)
CA (1) CA2082929A1 (xx)
DE (1) DE69227347T2 (xx)
DK (1) DK0529065T3 (xx)
IL (5) IL120082A (xx)
MX (1) MX9201113A (xx)
TW (1) TW324064B (xx)
WO (1) WO1992016845A1 (xx)
ZA (1) ZA921884B (xx)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
EP0594843B1 (en) * 1992-05-15 2004-11-03 Amylin Pharmaceuticals, Inc. Antibody assay for amylin
AU6249594A (en) * 1993-02-12 1994-08-29 Amylin Pharmaceuticals, Inc. Mcf-7 binding site assays
AU6524794A (en) * 1993-03-24 1994-10-11 Amylin Pharmaceuticals, Inc. Cloned receptors and methods for screening
GB9317193D0 (en) * 1993-08-18 1993-10-06 Zeneca Ltd Method
CZ69596A3 (en) * 1993-09-07 1997-06-11 Amylin Pharmaceuticals Inc Application of amylin, amylin agonist, amylin analog agonist or amylin antagonist for preparing a pharmaceutical preparation used for the control of gastrointestinal motility
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
AU5539596A (en) * 1995-04-06 1996-10-23 Amylin Pharmaceuticals, Inc. Anti-obesity agents
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
US6143718A (en) * 1995-06-07 2000-11-07 Amylin Pharmaceuticals, Inc. Treatment of Type II diabetes mellutis with amylin agonists
ATE493998T1 (de) * 1996-08-08 2011-01-15 Amylin Pharmaceuticals Inc Pharmazeutische zusammensetzung mit einem exendin-4-peptid
US5677279A (en) * 1996-12-16 1997-10-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treating pain with amylin or agonists thereof
AU739020B2 (en) 1997-01-07 2001-10-04 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the reduction of food intake
US7101853B2 (en) 1997-05-06 2006-09-05 Amylin Pharmaceuticals, Inc. Method for treating or preventing gastritis using amylin or amylin agonists
US7910548B2 (en) 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
WO1999005161A1 (en) * 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
EP1100888A2 (en) * 1998-05-26 2001-05-23 University Of Medicine And Dentistry Of New Jersey System for reproducing and modulating stability and turnover of rna molecules
US7399489B2 (en) * 1999-01-14 2008-07-15 Amylin Pharmaceuticals, Inc. Exendin analog formulations
DE60032331T2 (de) 1999-01-14 2007-06-21 Amylin Pharmaceuticals, Inc., San Diego Exendine zur glucagon suppression
US20030087820A1 (en) * 1999-01-14 2003-05-08 Young Andrew A. Novel exendin agonist formulations and methods of administration thereof
US6924264B1 (en) * 1999-04-30 2005-08-02 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
BR0010705A (pt) 1999-04-30 2002-02-05 Amylin Pharmaceuticals Inc Exendinas modificadas e agonistas da exendina
JP2003513281A (ja) * 1999-07-13 2003-04-08 アミリン・ファーマシューティカルズ，インコーポレイテッド 治療用化合物を同定するための最後野由来の膜、細胞および組織の使用
WO2002030471A2 (en) * 2000-10-10 2002-04-18 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien A novel system for the evaluation of the activity and/or specificity of a viral component
US20040005997A1 (en) * 2002-06-27 2004-01-08 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass of function using amylin receptors
EP1529061B1 (en) * 2002-08-06 2008-02-13 Sanofi-Aventis Deutschland GmbH Method for isolating an intestinal cholesterol binding protein
US8168233B2 (en) * 2002-10-18 2012-05-01 Amylin Pharmaceuticals, Inc. Treatment of pancreatitis with amylin
US20040214180A1 (en) * 2003-04-28 2004-10-28 Hironori Kobayashi Method and kit for determining quantity of protein
EP1663289A2 (en) * 2003-08-29 2006-06-07 Amylin Pharmaceuticals, Inc. Methods for treating or ameliorating ghrelin-associated diseases and disorders
US8114958B2 (en) * 2004-02-11 2012-02-14 Amylin Pharmaceuticals, Inc. Amylin family peptides
US7399744B2 (en) * 2004-03-04 2008-07-15 Amylin Pharmaceuticals, Inc. Methods for affecting body composition
JP2008515443A (ja) 2004-10-08 2008-05-15 アミリン・ファーマシューティカルズ，インコーポレイテッド 新規のアミリンファミリーポリペプチド−６（ａｆｐ−６）アナログならびにそれらの製法および使用方法
DE102004051014A1 (de) * 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
US8394765B2 (en) * 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
EP2127676A3 (en) 2004-11-01 2013-09-04 Amylin Pharmaceuticals, LLC Treatment of obesity and related disorders
US7879572B2 (en) * 2004-11-12 2011-02-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Regulation of F1-ATPase beta subunit cellular location
US7879794B2 (en) 2005-03-31 2011-02-01 Amylin Pharmaceuticals, Inc. Methods for controlling binge eating disorders
EP1912666A2 (en) * 2005-07-22 2008-04-23 Amylin Pharmaceuticals, Inc. Use of amylin and amylin agonists as cardioprotective or myoprotective agents
EA201070609A1 (ru) * 2007-11-14 2010-12-30 Амилин Фармасьютикалз, Инк. Способы лечения ожирения и ассоциированных с ожирением заболеваний и расстройств
CN102770152B (zh) 2009-11-25 2016-07-06 阿瑞斯根股份有限公司 肽类的粘膜递送
WO2015004632A1 (en) * 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize iapp

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434236A (en) * 1982-10-20 1984-02-28 E. I. Du Pont De Nemours & Co. Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
DE68924372T2 (de) * 1988-01-11 1996-05-09 Amylin Pharmaceuticals Inc Behandlung von diabetes mellitus typ 2.
ES2080802T3 (es) * 1989-07-10 1996-02-16 Amylin Pharmaceuticals Inc Uso de un antagonista de amilina en la preparacion de un medicamento para el tratamiento de la obesidad e hipertension intrinseca y desordenes asociados.

Also Published As

Publication number Publication date
US5264372A (en) 1993-11-23
TW324064B (en) 1998-01-01
JPH05508226A (ja) 1993-11-18
IL120081A0 (en) 1997-04-15
DE69227347D1 (de) 1998-11-26
EP0529065B1 (en) 1998-10-21
IL101233A (en) 1997-04-15
ZA921884B (en) 1993-08-03
AU1663092A (en) 1992-10-21
EP0529065A4 (en) 1993-10-20
IL120082A (en) 1998-12-27
EP0529065A1 (en) 1993-03-03
MX9201113A (es) 1992-10-01
ATE172540T1 (de) 1998-11-15
DK0529065T3 (da) 1999-06-28
WO1992016845A1 (en) 1992-10-01
IL120081A (en) 1998-12-27
CA2082929A1 (en) 1992-09-16
IL101233A0 (en) 1992-11-15
DE69227347T2 (de) 1999-03-18

Similar Documents

Publication Publication Date Title
IL120082A0 (en) Method for determining the amount of an amylin receptor binding compound in a sample
PT1015608E (pt) Metodos de ensaio de actividade de receptor e construcoes uteis nesses metodos
EP0290921A3 (en) Test-piece for the analysis of a liquid sample and method for its preparation
PT99618A (pt) Processo para a realizacao de um ensaio de ligacao a recptores celulares isentode celulas e de identificacao caracterizacao e deteccao de agentes biologicos por meio desse ensaio
ES2101802T3 (es) Ensayo para determinar los niveles de igf-i, igf-ii y gh libres en liquidos corporales.
DE69113634D1 (de) Probenträger für ein automatisches gerät zur analyse von proben.
NO20083610L (no) Cobalamin-maling
EP1012241A4 (en) SCREENING ASSAYS FOR G PROTEIN COUPLED RECEPTOR AGONISTS AND ANTAGONISTS
WO2000007017A3 (en) Method of high-throughput screening
ZA912303B (en) Protein partner screening assays and uses thereof
ES2168310T3 (es) Reactivos y metodos de deteccion y de cuantificacion de la testosterona en muestras de fluido.
DE69326575D1 (de) Testverfahren für Proben unter Verwendung flacher Probenträger
ZA905132B (en) Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
EP0134798A4 (en) Preservative additive for a milk sample to be tested for composition and method for separating milk samples using the same.
DK0677117T3 (da) Sondring mellem HTLV-I og HTLV-II under anvendelse af syntetiske peptider
EP1079230A4 (en) METHOD FOR SEARCHING FOR A SUBSTANCE PROMOTING OLIGOMERIZATION OF RECEPTOR PROTEIN MOLECULES
IL160531A0 (en) Compositions and methods for aa4rp assay
TH18474A (th) ลำดับดีเอนเอที่มีรหัสสำหรับหน่วยรับ bmp
ATE195803T1 (de) Verfahren zum vorhersagen der verdaulichkeit von futtermaterialien
AU2001259172A8 (en) Apparatus and methods for assays of one or more analytes